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Background and PurposeaaScoliosis is more common in patients with Parkinson’s disease 
(PD) than in the general elderly population. We compared clinical characteristics between PD 
patients with and without scoliosis, to identify the relationship between the direction of sco-
liosis and the laterality of the dominant symptoms of PD. We also studied the associations be-
tween dopaminergic pharmacotherapy and scoliosis (defined by a spinal curvature deviation of 
10° or larger). 
MethodsaaThe study population comprised 97 patients (42 men and 55 women) with idiopa-
thic PD. All of the patients submitted to a whole-spine scanograph to allow measurement of the 
degree of scoliosis by Cobb’s method. 
ResultsaaTrue scoliosis was found in 32 of the 97 PD patients, and was observed more frequ-
ently in women than in men (28 vs. 4, respectively; p=0.006). The age of patients without sco-
liosis was significantly lower than that of those with scoliosis (66.5±9.2 years vs. 72.8±7.3 years, 
respectively, mean±SD, p<0.001). There was no correlation between PD symptom laterality and 
scoliosis. The rate of occurrence of scoliosis did not differ between de novo and levodopa (L-
dopa)-treated patients. 
ConclusionsaaWe suggest that neither L-dopa treatment nor the laterality of the initial symp-
toms of PD is related to the appearance of scoliosis.  J Clin Neurol 2009;5:91-94
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Introduction 
 
Scoliosis is defined as lateral curvature of the spine with ver-
tebral rotation leading to asymmetric deformity of the trunk. 
It occurs more frequently in patients with Parkinson’s disease 
(PD) than in the general population.
1-4  
Several clinical and animal studies have reported that the 
direction of scoliosis is congruous with the laterality of the 
major signs and symptoms of PD,
3,5-7 suggesting that scolio-
sis is closely associated with nigrostriatal dopamine deficiency. 
However, contradictory results have also been reported.
8 The 
relationship between dopaminergic pharmacotherapy and the 
direction of scoliosis in PD is also poorly understood.   
We divided PD patients into two groups according to the 
degree of spinal curvature: those with spinal asymmetry (non 
scoliosis) and those with true scoliosis. We compared the cli-
nical characteristics of the two groups and studied the rela-
tionship between the laterality of PD symptoms and the direc-
tion of scoliosis. We also studied the association between do-
paminergic pharmacotherapy and the risk of developing sco-
liosis in patients with PD. 
 
Methods 
 
Patients 
This prospective study was carried out at an outpatient clinic 
of the Movement Disorders Clinics of Sanggye Paik Hospi-
tal (a tertiary, university-affiliated medical center in Seoul), 
between January 1 and December 31, 2007. This study in-
cluded PD patients fulfilling United Kingdom Brain Bank 
Criteria,
9 and excluded those with atypical parkinsonism, se-
condary parkinsonism, long-standing idiopathic scoliosis, and 
previous cerebral infarction or head trauma. The degree of 
scoliosis was assessed using whole-spine radiography, and  
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the Unified Parkinson’s Disease Rating Scale Motor Score 
(UPDRS III)
10 and the Hoehn and Yahr (H&Y)
11 scores were 
evaluated. The clinical characteristics of the cohort were de-
termined (including age at initial evaluation, gender, initial 
symptom side, age of PD symptom onset, surgery and back 
pain history, and drug treatment) by questioning the subjects 
and their caregivers, and studying their medical records. Pa-
tients who were medicated with levodopa (L-dopa) during ON 
time were identified. Informed, written consent to participate 
was obtained from the patients after they had been given a com-
plete description of the whole-spine scanograph procedure. 
 
Radiological examination and analysis 
Scoliosis was evaluated from an upright posteroanterior ra-
diograph of the entire spine of each patient. If a patient was 
unable to stand upright for a whole-spine scanograph, a sim-
ple spine X-ray was performed. The degree, location, and di-
rection of the scoliosis curve were assessed. Digital X-ray 
films and the Cobb method were used to measure the curve,
12 
and the degree of curvature was measured automatically with 
the aid of a digital X-ray viewing system (Fig. 1). Using the 
findings, we divided patients into those with normal or spi-
nal asymmetry (deviation of less than 10°), and those with 
scoliosis (deviation of 10° or more).
13 All digital films were 
evaluated by a radiologist. Curve location was defined by its 
center, known as the apex, which is the most lateral disc or 
vertebra of the curve. The scoliosis cases were then subdi-
vided according to the apical vertebra into cervical, thoracic, 
and lumbar cases. The direction of curvature was defined as 
direction of convexity.   
Data were analyzed with the statistical package SPSS for 
Windows (version 12.0, SPSS, Chicago, Illinois, USA). De-
mographic data comparisons between the spinal asymmetry 
and scoliosis groups were conducted using unpaired t-tests 
and χ2 statistics. The level of statistical significance was set 
at p<0.05.  
 
Results 
 
A total of 97 PD patients (42 men and 55 women) comprised 
the cohort for this study. The age of onset of PD was 65.0± 
9.7 years (mean±SD; range 37-88 years), and the duration of 
the disease was 39.9±30.0 months (range 1-103 months). 
The H&Y stage was 1.6±0.7 (range 1-3), and the UPDRS III 
score was 22.5±14.7 (range 4-83). Thirty-two of the 97 pa-
tients (33%) had scoliosis: 2 (5.6%) at the cervico thoracic 
junction, 7 (19.4%) in the thoracic spine, 13 (36.1%) at the 
thoraco lumbar junction, and 14 (38.9%) in the lumbar spine. 
Four of the 32 patients had double curves. The side on which 
PD symptoms were more severe was right in 50 patients and 
left in 47. In 38 of 97 patients the initial dominant symptom 
was akinetic-rigid syndrome, in 30 it was tremor, and in 29 it 
was a combination of both.   
The various clinical characteristics were compared between 
patients with and without scoliosis. Patients with scoliosis 
were significantly older (72.8±7.3 years) than those without 
(66.5±9.2 years, p<0.001), and scoliosis was observed in wo-
men 7 times more frequently than in men (28 women vs. 4 
men, p=0.006). There were no significant differences in any 
of the other clinical characteristics (Table 1). The relationship 
between dopaminergic pharmacotherapy and scoliosis was ev-
aluated by comparing de novo and L-dopa-treated patients; 
with the exception of disease duration there were no signifi-
cant differences between the clinical features of the two 
groups (Table 2). The direction of scoliosis was concordant 
with PD laterality in 8 out of 18 treated patients (44.4%) and 
in 8 out of 14 de novo patients (57.1%).  
 
Discussion 
 
Scoliosis is a structural lateral curvature of the spine with a 
rotator component. The incidence of scoliosis among healthy 
elderly patients varies from 6% to 30%,
1,2 but this figure rise 
in PD ranging from 43% to 90%.
3,4,8 Ashour and Jankovic
14 
Fig. 1. A 65-year-old female de novo patient, with a 1-year history
of bradykinesia on the left side exhibited right-sided scoliosis in
the lumbar area with a deviation 16.32° (as assessed using the
Cobb method and whole-spine scanography).  
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recently reported 14 patients with scoliosis among a total of 
164 PD patients (i.e., 8.5%). Their study was retrospective 
and radiological evaluation was not performed. However, the 
present study cohort of 97 included 32 PD patients (33%) with 
scoliosis with a deviation of 10° or more.   
Genetic, hormonal, biomechanical, and neuromuscular fac-
tors have been proposed as possible causes of scoliosis in PD, 
but its exact pathophysiology is not yet understood.
15 In ac-
cordance with the frequent dystonia reported in women with 
PD,
16 the present study showed that scoliosis occurred seven 
times more frequently in women with PD than in their male 
counterparts. Our data also show that old-age onset of PD is 
another risk factor for scoliosis in PD.   
Duvoisin and Marsden showed that 19 of 21 consecutive 
unoperated PD patients had the same direction of postural 
deviation, which was correlated significantly with the latera-
lity of the major signs and symptoms of their parkinsonism.
3 
They considered the scoliosis to be analogous to that observ-
ed in animals after unilateral destruction of the dopaminergic 
nigrostriatal pathway arising from the zona compacta of the 
substantia nigra.
17 Recent studies have shown that experimen-
tal central nervous system lesions induce scoliosis.
6,7 Axial dys-
tonias, such as camptocormia, Pisa syndrome, or scoliosis, 
could be caused by bilateral involvement of the brain stem 
ascending dopamine pathways.
18 However, the present study 
found that the laterality of PD symptoms and the severity of 
parkinsonian deficits were not related to the direction and 
development of scoliosis. Similar to the present study, other 
study showed no relationship between the direction of sco-
liosis and laterality of Parkinsonian signs.
8 Although it has 
been shown previously that the frequency and severity of dys-
tonic posture are correlated with the duration of L-dopa 
Table 2. Clinical characteristics of de novo and L-dopa-treated patients 
    De novo  L-dopa-treated  p 
Total number of patients    43 54   
Gender (males : females)    18 : 25 (1 : 1.39) 24  : 30 (1 : 1.25) 0.930 
Age, years (mean±SD and range)    67.12±9.91 (43-90) 69.76±8.17 (42-85) 0.153 
Duration of PD, months (mean±SD and range)    19.84±18.81 (1-83) 55.00±26.98 (6-98) <0.001 
Initial PD symptom, n (%)        
Tremor    00012 (27.9%)  00018 (33.3%) 0.726 
Akinetic-rigid    00014 (32.6%)  00024 (44.4%) 0.330 
Tremor+akinetic-rigid    00017 (39.5%)  00012 (22.3%) 0.106 
H&Y stage (mean±SD and range)    1.44±0.64 (1-3) 1.64±0.64 (1-3) 0.140 
UPDRS III (mean±SD and range)    21.65±17.46 (5-83) 23.10±12.32 (4-51) 0.683 
History of back pain, n (%)    12/19 (63.2%) 25/43  (58.1%) 0.923 
Previous surgery, n (%)    05/28 (17.9%) 5/52  (9.6%) 0.474 
Scoliosis patients, n (%)    14/43 (32.6%) 18/54  (33.3%) 0.885 
PD: Parkinson’s disease, H&Y: Hoehn and Yahr, UPDRS III: Unified Parkinson’s Disease Rating Scale Motor Score, L-dopa: levodopa. 
 
Table 1. Clinical characteristics of non-scoliosis and true scoliosis patients 
    Non-scoliosis  True scoliosis  p 
Total number of patients    65 32   
Gender (males : females)    38 : 27 (1 : 0.71) 4  : 28 (1 : 7.00) <0.001 
Age, years (mean±SD and range)    66.53±9.15 (43-85) 72.75±7.29 (55-90) <0.001 
Duration of PD, month (mean±SD and range) 40.65±29.72 (4-98) 36.91±29.07 (1-95) 0.559 
Initial PD symptom, n (%)        
Tremor    00018 (27.7%)  00012 (37.5%) 0.454 
Akinetic-rigid    00026 (40.0%)  00012 (37.5%) 0.987 
Tremor+akinetic-rigid    00021 (32.3%)  00008 (25.0%) 0.615 
H&Y stage (mean±SD and range)    1.52±0.61 (1-3) 1.64±0.73 (1-3) 0.379 
UPDRS III (mean±SD and range)    22.67±12.21 (5-51) 21.89±20.38 (4-83) 0.847 
History of back pain, n (%)    22/42 (52.4%) 15/20  (75.0%) 0.156 
Previous surgery, n (%)    06/54 (11.2%)  04/28 (14.3%) 0.959 
De novo patients, n (%)    29/65 (44.6%) 14/32  (43.8%) 0.887 
L-dopa-treated patients, n (%)    00035 (53.9%)  00018 (56.3%) 0.995 
PD: Parkinson’s disease, H&Y: Hoehn and Yahr, UPDRS III: Unified Parkinson’s Disease Rating Scale Motor Score, L-dopa: levodopa. 
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treatment,
16 we could not find any relationship between sco-
liosis and medical treatment. These findings suggest that nig-
rostriatal dopamine deficiency is not a major causative factor 
in the development of scoliosis. 
Degenerative scoliosis is usually associated with a vari-
able degree of loss of lordosis, axial rotation, lateral listhesis, 
and spondylolisthesis.
13 Other than scoliosis, our patients had 
no spinal abnormalities. The other possible explanation is os-
teoporosis; however, some of the patients included in this 
study, especially those with scoliosis in the lower lumbar area, 
may have had degenerative scoliosis. Osteoporosis and lum-
bar scoliosis are known to be diseases of the elderly that occur 
particularly frequently in women and often occur together.
19,20 
Although some studies have shown no correlation between 
osteoporosis and scoliosis,
1,21 others have shown that the pre-
valence of scoliosis is higher among the elderly with oste-
oporosis.
19,20,22 However, the present study showed that only 
38.9% of patients (14 of 36 lesions) had scoliosis in the 
lumbar area, which is the site most frequently affected by the 
degenerative scoliosis associated with osteoporosis.   
Our study has some limitations. One is that most of our 
patients had relatively mild PD symptoms (mean H&Y stage 
1.6). This makes it difficult to compare our findings with 
those of patients with advanced PD. Another limitation of 
our study is that we did not include control population. Also, 
it’s difficult to discern the base rate of scoliosis by age, be-
cause our data may contain many elderly individuals with 
mild scoliosis.   
In spite of these limitations, our results suggest that sco-
liosis in PD is not related to any of the clinical manifesta-
tions of PD, including disease severity (H&Y stage, UPDRS 
III scores), and that the direction of scoliosis convexity is not 
related to the laterality of initial PD symptoms. Although the 
incidence and severity of dystonic posture are correlated with 
L-dopa treatment in PD-associated dystonia, we could not 
find any correlation with L-dopa treatment in PD-associated 
scoliosis.  
In conclusion, scoliosis in patients with PD is common, 
most having a single curvature. Scoliosis is more common in 
women than men, and the onset age of PD in patients with 
scoliosis is older than in those without. The presence of sco-
liosis in PD patients is not related to the mean duration of PD, 
initial dominant symptoms, UPDRS III scores, and L-dopa 
treatment. Although we did not compare all of the clinical 
features between the concordance and non-concordance groups, 
it appears that the direction of scoliosis may not be correlated 
with the laterality of the major signs and symptoms of par-
kinsonism or with L-dopa treatment. 
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